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The malaria community has moved rapidly from accep-
tance of the possibility of elimination in some countries
to an active discussion about eventual human malaria
eradication, perhaps by 2050. If this ambitious goal is to
be achieved, several things are necessary.
First, we must have a clear overall strategy for the
achievement of malaria eradication. This involves three
equally important elements:
• Aggressive control in the heartland to bring malaria
burden from high to low.
• Shrinking the malaria map by eliminating transmis-
sion in countries at the endemic margins.
• Research to bring forward new drugs, vaccines,
insecticides and other tools and technologies.
Second, we must have a clear roadmap leading to eradi-
cation in 2050. If all countries have eliminated by 2050,
what must the 2040 map look like? What must the 2030
map look like? And so on. We must set ambitious but
achievable five-yearly targets. These must be accompanied
by research timelines for the discovery of new and better
tools and technologies.
Third, we must aggressively use today’s tools today
and be ready to adopt and rapidly scale-up tomorrow’s
tools for tomorrow.
Fourth, we must work to strengthen both national pro-
grams and regional collaborations. Two significant regio-
nal collaborations, APMEN and E8, provide models.
Fifth, we must overcome specific technical challenges
including artemisinin-resistant P. falciparum, Plasmodium
knowlesi, cross-border malaria movement, and the sys-
temically weak management that is found in most
National Malaria Control Programs.
Sixth, we must ensure adequate finance, not only to
reach elimination, but to prevent reintroduction. The
possibility of declining budgets in the face of declining
malaria, and no budgets in the face of no malaria, is ever
present. Sri Lanka in the 1960s will repeat itself if we are
not proactive. We vaccinate against measles where there
is no measles. We need to invest in malaria control
where there is no malaria.
Finally, we must continue to transition from a science-
led malaria endeavor to a science-supported malaria
endeavor. Scientists will always focus on what we do not
know and on the lack of evidence to support aggressive
action. Leadership needs to come from those who are
experienced in bold action based on sufficient evidence, to
create a more ambitious trajectory toward eradication.
And this leadership needs to be supported by the best
scientists and the most vigorous development of new pro-
ducts and tools. Linked to this culture of action, must be
an emphasis on operational research and learning while
doing.
With these and other commitments and efforts, we
can collectively embrace the vision of a planet with no
human malaria by 2050.
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